SEB Asset Management’s DexCom DXCM Stock Holding History

SEB Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6M	Buy	379,779 +2,715	+0.7%	+$181K	0.1%	187
2026 Q1	$23.7M	Buy	+377,064	New	+$26.3M	0.1%	176

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SEB Asset Management's DXCM Position: Q2 2026 in Review

SEB Asset Management increased its DexCom (DXCM) stake by 0.72% in Q2 2026, buying an estimated $181K and bringing the position to 379,779 shares worth $25.6M. The position accounts for 0.1% of the portfolio, ranked #187.

SEB Asset Management first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

SEB Asset Management held 379,779 shares of DexCom worth $25.6M as of Q2 2026.
SEB Asset Management bought 2,715 DexCom shares in Q2 2026, an estimated $181K.
DexCom made up 0.1% of SEB Asset Management's portfolio in Q2 2026, its #187 holding.
SEB Asset Management first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.